These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34664682)

  • 1. Role of Nectin‑4 protein in cancer (Review).
    Liu Y; Han X; Li L; Zhang Y; Huang X; Li G; Xu C; Yin M; Zhou P; Shi F; Liu X; Zhang Y; Wang G
    Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34664682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nectin4/PRR4, a new afadin-associated member of the nectin family that trans-interacts with nectin1/PRR1 through V domain interaction.
    Reymond N; Fabre S; Lecocq E; Adelaïde J; Dubreuil P; Lopez M
    J Biol Chem; 2001 Nov; 276(46):43205-15. PubMed ID: 11544254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prominent role of the Ig-like V domain in trans-interactions of nectins. Nectin3 and nectin 4 bind to the predicted C-C'-C"-D beta-strands of the nectin1 V domain.
    Fabre S; Reymond N; Cocchi F; Menotti L; Dubreuil P; Campadelli-Fiume G; Lopez M
    J Biol Chem; 2002 Jul; 277(30):27006-13. PubMed ID: 12011057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum nectin-2 and nectin-4 are diagnostic in lung cancer: which is superior?
    Erturk K; Karaman S; Dagoglu N; Serilmez M; Duranyildiz D; Tas F
    Wien Klin Wochenschr; 2019 Sep; 131(17-18):419-426. PubMed ID: 31440821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nectin cell adhesion molecule 4 regulates angiogenesis through Src signaling and serves as a novel therapeutic target in angiosarcoma.
    Tanaka Y; Murata M; Tanegashima K; Oda Y; Ito T
    Sci Rep; 2022 Mar; 12(1):4031. PubMed ID: 35256687
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Klümper N; Tran NK; Zschäbitz S; Hahn O; Büttner T; Roghmann F; Bolenz C; Zengerling F; Schwab C; Nagy D; Toma M; Kristiansen G; Heers H; Ivanyi P; Niegisch G; Grunewald CM; Darr C; Farid A; Schlack K; Abbas M; Aydogdu C; Casuscelli J; Mokry T; Mayr M; Niedersüß-Beke D; Rausch S; Dietrich D; Saal J; Ellinger J; Ritter M; Alajati A; Kuppe C; Meeks J; Vera Badillo FE; Nakauma-González JA; Boormans J; Junker K; Hartmann A; Grünwald V; Hölzel M; Eckstein M
    J Clin Oncol; 2024 Jul; 42(20):2446-2455. PubMed ID: 38657187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Nectin4/FAP-targeted CAR-T cells secreting IL-7, CCL19, and IL-12 for malignant solid tumors.
    Li F; Zhao S; Wei C; Hu Y; Xu T; Xin X; Zhu T; Shang L; Ke S; Zhou J; Xu X; Gao Y; Zhao A; Gao J
    Front Immunol; 2022; 13():958082. PubMed ID: 36479116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy.
    Chatterjee S; Sinha S; Kundu CN
    Eur J Pharmacol; 2021 Nov; 911():174516. PubMed ID: 34547246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NECTIN4: A Novel Therapeutic Target for Melanoma.
    Tanaka Y; Murata M; Shen CH; Furue M; Ito T
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nectin-3, a new member of immunoglobulin-like cell adhesion molecules that shows homophilic and heterophilic cell-cell adhesion activities.
    Satoh-Horikawa K; Nakanishi H; Takahashi K; Miyahara M; Nishimura M; Tachibana K; Mizoguchi A; Takai Y
    J Biol Chem; 2000 Apr; 275(14):10291-9. PubMed ID: 10744716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate.
    Boylan KL; Buchanan PC; Manion RD; Shukla DM; Braumberger K; Bruggemeyer C; Skubitz AP
    Oncotarget; 2017 Feb; 8(6):9717-9738. PubMed ID: 28038455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of Nectin-2 reveals determinants of homophilic and heterophilic interactions that control cell-cell adhesion.
    Samanta D; Ramagopal UA; Rubinstein R; Vigdorovich V; Nathenson SG; Almo SC
    Proc Natl Acad Sci U S A; 2012 Sep; 109(37):14836-40. PubMed ID: 22927415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT.
    Hao RT; Zheng C; Wu CY; Xia EJ; Zhou XF; Quan RD; Zhang XH
    Cancer Manag Res; 2019; 11():2565-2578. PubMed ID: 31114323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation.
    Takai Y; Miyoshi J; Ikeda W; Ogita H
    Nat Rev Mol Cell Biol; 2008 Aug; 9(8):603-15. PubMed ID: 18648374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NECTIN4 Expression in Extramammary Paget's Disease: Implication of a New Therapeutic Target.
    Murata M; Ito T; Tanaka Y; Kaku-Ito Y; Furue M
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-mesenchymal transition enhances response to oncolytic herpesviral therapy through nectin-1.
    Chen CH; Chen WY; Lin SF; Wong RJ
    Hum Gene Ther; 2014 Jun; 25(6):539-51. PubMed ID: 24568312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nectin spot: a novel type of nectin-mediated cell adhesion apparatus.
    Mizutani K; Takai Y
    Biochem J; 2016 Sep; 473(18):2691-715. PubMed ID: 27621480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nectin Cell Adhesion Molecule 4 (NECTIN4) Expression in Cutaneous Squamous Cell Carcinoma: A New Therapeutic Target?
    Tanaka Y; Murata M; Oda Y; Furue M; Ito T
    Biomedicines; 2021 Mar; 9(4):. PubMed ID: 33808400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nectin4 is an epithelial cell receptor for canine distemper virus and involved in neurovirulence.
    Pratakpiriya W; Seki F; Otsuki N; Sakai K; Fukuhara H; Katamoto H; Hirai T; Maenaka K; Techangamsuwan S; Lan NT; Takeda M; Yamaguchi R
    J Virol; 2012 Sep; 86(18):10207-10. PubMed ID: 22761370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nectin-4 has emerged as a compelling target for breast cancer.
    Wang H; Sun D; Chen J; Li H; Chen L
    Eur J Pharmacol; 2023 Dec; 960():176129. PubMed ID: 38059449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.